发明名称 FUSED-RING 4-OXOPYRIMIDINE DERIVATIVE
摘要 The present invention provides a compound represented by formula (I) below, or a pharmaceutically acceptable salt thereof, which, having histamine H3 receptor antagonist or inverse agonist activity, is useful in the prophylaxis or therapy of metabolic diseases, circulatory diseases, or nervous system diseases. (see formula I) where, for example, Ar is a divalent group formed by eliminating two hydrogen atoms from benzene, X1 is a nitrogen atom, sulfur atom or oxygen atom, R1 is a 5- to 6-membered heteroaryl group, Ring A is a 5-to 6-membered heteroaryl ring, R2 and R3 are amino groups or alkylamino groups, and X2 is represented by formula (II): (see formula II) (where R4 and R5 are lower alkyl groups, and n is an integer from 2 to 4).
申请公布号 CA2555824(C) 申请公布日期 2011.06.07
申请号 CA20052555824 申请日期 2005.02.14
申请人 BANYU PHARMACEUTICAL CO., LTD. 发明人 NAGASE, TSUYOSHI;SATO, NAGAAKI;KANATANI, AKIO;TOKITA, SHIGERU
分类号 C07D471/04;A61K31/4725;A61K31/517;A61K31/519;A61K31/55;A61K45/06;A61P1/16;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P3/12;A61P5/00;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P13/12;A61P19/06;A61P25/00;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P43/00;C07D217/24;C07D239/70;C07D239/91;C07D401/04;C07D401/12;C07D403/04;C07D403/12;C07D487/08 主分类号 C07D471/04
代理机构 代理人
主权项
地址